235 related articles for article (PubMed ID: 26408423)
1. Pancreatic cyst fluid concentration of high-mobility group A2 protein acts as a differential biomarker of dysplasia in intraductal papillary mucinous neoplasm.
DiMaio CJ; Weis-Garcia F; Bagiella E; Tang LH; Allen PJ
Gastrointest Endosc; 2016 Jun; 83(6):1205-9. PubMed ID: 26408423
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E
Yip-Schneider MT; Carr RA; Wu H; Schmidt CM
J Am Coll Surg; 2017 Oct; 225(4):481-487. PubMed ID: 28739154
[TBL] [Abstract][Full Text] [Related]
3. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
4. Cyst fluid carcinoembryonic antigen level is not predictive of invasive cancer in patients with intraductal papillary mucinous neoplasm of the pancreas.
Kucera S; Centeno BA; Springett G; Malafa MP; Chen YA; Weber J; Klapman J
JOP; 2012 Jul; 13(4):409-13. PubMed ID: 22797397
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic Fluid Interleukin-1β Complements Prostaglandin E2 and Serum Carbohydrate Antigen 19-9 in Prediction of Intraductal Papillary Mucinous Neoplasm Dysplasia.
Simpson RE; Yip-Schneider MT; Flick KF; Wu H; Colgate CL; Schmidt CM
Pancreas; 2019 Sep; 48(8):1026-1031. PubMed ID: 31404023
[TBL] [Abstract][Full Text] [Related]
6. Cyst Fluid Analysis in Pancreatic Intraductal Papillary Mucinous Neoplasms.
Allen PJ; Iacobuzio-Donahue CA; Klimstra DS
Clin Cancer Res; 2016 Oct; 22(20):4966-4967. PubMed ID: 27573170
[TBL] [Abstract][Full Text] [Related]
7. Tumor-associated Neutrophils and Malignant Progression in Intraductal Papillary Mucinous Neoplasms: An Opportunity for Identification of High-risk Disease.
Sadot E; Basturk O; Klimstra DS; Gönen M; Lokshin A; Do RK; D'Angelica MI; DeMatteo RP; Kingham TP; Jarnagin WR; Allen PJ
Ann Surg; 2015 Dec; 262(6):1102-7. PubMed ID: 25563865
[TBL] [Abstract][Full Text] [Related]
8. Cyst Fluid Biosignature to Predict Intraductal Papillary Mucinous Neoplasms of the Pancreas with High Malignant Potential.
Maker AV; Hu V; Kadkol SS; Hong L; Brugge W; Winter J; Yeo CJ; Hackert T; Büchler M; Lawlor RT; Salvia R; Scarpa A; Bassi C; Green S
J Am Coll Surg; 2019 May; 228(5):721-729. PubMed ID: 30794864
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
Maker AV; Katabi N; Gonen M; DeMatteo RP; D'Angelica MI; Fong Y; Jarnagin WR; Brennan MF; Allen PJ
Ann Surg Oncol; 2011 Jan; 18(1):199-206. PubMed ID: 20717734
[TBL] [Abstract][Full Text] [Related]
10. Cyst fluid interleukin-1beta (IL1beta) levels predict the risk of carcinoma in intraductal papillary mucinous neoplasms of the pancreas.
Maker AV; Katabi N; Qin LX; Klimstra DS; Schattner M; Brennan MF; Jarnagin WR; Allen PJ
Clin Cancer Res; 2011 Mar; 17(6):1502-8. PubMed ID: 21266527
[TBL] [Abstract][Full Text] [Related]
11. Plectin-1 as a Biomarker of Malignant Progression in Intraductal Papillary Mucinous Neoplasms: A Multicenter Study.
Moris M; Dawson DW; Jiang J; Lewis J; Nassar A; Takeuchi KK; Lay AR; Zhai Q; Donahue TR; Kelly KA; Crawford HC; Wallace M
Pancreas; 2016 Oct; 45(9):1353-8. PubMed ID: 27101571
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor II messenger RNA-binding protein-3 is a valuable diagnostic and prognostic marker of intraductal papillary mucinous neoplasm.
Morimatsu K; Aishima S; Yamamoto H; Hayashi A; Nakata K; Oda Y; Shindo K; Fujino M; Tanaka M; Oda Y
Hum Pathol; 2013 Sep; 44(9):1714-21. PubMed ID: 23597774
[TBL] [Abstract][Full Text] [Related]
13. Distinct patterns of peritumoral histological findings in subtypes of intraductal papillary mucinous neoplasms of the pancreas.
Saito M; Imada H; Suzuki T; Sata N; Yasuda Y; Maetani I; Fukushima N
Ann Diagn Pathol; 2015 Oct; 19(5):347-52. PubMed ID: 26265194
[TBL] [Abstract][Full Text] [Related]
14. Simple Detection of Telomere Fusions in Pancreatic Cancer, Intraductal Papillary Mucinous Neoplasm, and Pancreatic Cyst Fluid.
Hata T; Dal Molin M; McGregor-Das A; Song TJ; Wolfgang C; Eshleman JR; Hruban RH; Goggins M
J Mol Diagn; 2018 Jan; 20(1):46-55. PubMed ID: 29229290
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.
Takeshita A; Kimura W; Hirai I; Takasu N; Moriya T; Tezuka K; Watanabe T
Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341
[TBL] [Abstract][Full Text] [Related]
16. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
[TBL] [Abstract][Full Text] [Related]
17. mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).
Das KK; Xiao H; Geng X; Fernandez-Del-Castillo C; Morales-Oyarvide V; Daglilar E; Forcione DG; Bounds BC; Brugge WR; Pitman MB; Mino-Kenudson M; Das KM
Gut; 2014 Oct; 63(10):1626-34. PubMed ID: 24277729
[TBL] [Abstract][Full Text] [Related]
18. miRNA biomarkers in cyst fluid augment the diagnosis and management of pancreatic cysts.
Matthaei H; Wylie D; Lloyd MB; Dal Molin M; Kemppainen J; Mayo SC; Wolfgang CL; Schulick RD; Langfield L; Andruss BF; Adai AT; Hruban RH; Szafranska-Schwarzbach AE; Maitra A
Clin Cancer Res; 2012 Sep; 18(17):4713-24. PubMed ID: 22723372
[TBL] [Abstract][Full Text] [Related]
19. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Cancer.
Majumder S; Philip NA; Singh Nagpal SJ; Takahashi N; Mara KC; Kendrick ML; Smyrk TC; Zhang L; Levy MJ; Gleeson FC; Petersen BT; Pearson RK; Topazian MD; Vege SS; Chari ST
Am J Gastroenterol; 2019 Mar; 114(3):524-529. PubMed ID: 30413822
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous and sequential combination of genetic and epigenetic biomarkers for the presence of high-grade dysplasia in patients with pancreatic cyst: Discovery in cyst fluid and test in pancreatic juice.
Hata T; Mizuma M; Kusakabe T; Amano H; Furukawa T; Iwao T; Unno M
Pancreatology; 2023 Mar; 23(2):218-226. PubMed ID: 36707261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]